Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 250

Where does financial advice need to head?

Unless the obvious 'elephant in the room', the product/advice conflict, is addressed head on, any attempt to respond to the Royal Commission’s exposure of poor behaviour and inappropriate advice with more legislation is likely to continue to prove costly and ineffective.

The 'best interests' protections in the current legislation skirt around the issue and have already failed to prevent the selling of inappropriate products by advisers linked to product manufacturers. A fatal flaw is the reliance on 'reasonableness' to test various aspects of 'acting in the best interests of the client'.

'Reasonableness' is simply too low a standard when account is taken of the diverse range of skills and knowledge possessed by financial planners. There is no industry consensus on what body of knowledge all planners should subscribe to or what is regarded as best practice on the many aspects of personal finance.

Doctors provide a model for financial advisers

Medicine has had a long history of grappling with issues of professionalism and the separation of product from advice. The AMA’s 'Position Statement on Doctors’ Relationship with Industry 2010' potentially provides a model for the personal finance industry. Replacing 'doctor' with 'financial planner' (and other appropriate substitutions) in Section 3 of their Position Statement sets a standard for financial advice:

3.1 The major principles guiding [financial planners’] relationships with industry include the following:

  • The [financial planner’s] primary obligation is to the [client]. Considerations involving industry are appropriate only insofar as they do not intrude or distort that primary obligation; 

  • The primary objective of relationships between [financial planners] and industry should be the advancement of the [financial] health of [clients]; 

  • [Financial planners] must maintain their professional autonomy (bold added), [advice] independence and integrity. Relationships between [financial planners] and industry must not compromise [financial planners’] professional judgement or ability to act in their [clients’] best interests 

  • The [client’s] [financial] health needs should be the primary consideration when utilising products and services; 

  • [Financial planners] should manage potential conflicts of interest appropriately so as to maintain the public’s trust and confidence in the [financial planning] profession. Appropriate management may include, but is not limited to, timely and honest disclosure of relevant relationships with industry to [clients], peers, ethics committees, and others in a transparent and accountable manner as well as eliminating the potential for conflicts of interest to develop.

Adoption of Section 9.2 would require:

[Financial planners] in practice should not ask for or accept a fee, loans, or equivalent consideration from industry in exchange for seeing them in a promotional or similar capacity.

The notion that a doctor could be employed or authorised to practice by a pharmaceutical company, for example, would be regarded as outrageous by both the medical profession and the public (although we know dubious practices still occur, showing it is impossible to remove all rogues from any industry).

Until advice is effectively separated from product, either by legislation or self-regulation, consumers cannot be confident that the requirements of the product manufacturer are not unduly influencing the advice. 

Future directions and practical next steps 

I am not naive enough to believe that separation along the lines that exists between doctors and industry will occur immediately. Although desirable in the long term, in the short term it would be very disruptive for product manufacturers to disband their large distribution networks.

A better alternative is to make a legislative distinction between aligned (to a product manufacturer) and non-aligned advisers. Key aspects of this distinction could include the following:

  • Aligned advisers would be required to clearly state and have acknowledged by clients the nature of their alignment and that their advice may conflict with the best interests of the client i.e. no 'best interests' duty. They should also be required to inform potential clients of the existence of non-aligned advisers and their 'best interests' obligation.

  • Aligned advisers would not be able to call themselves 'financial planners' or 'financial advisers', but something along the lines of 'financial product sales consultants' or 'financial services agents'. The titles 'financial planner' and 'financial adviser' would be strictly defined.

  • Non-aligned advisers would have a general 'best interests' duty to clients, that need not be as prescriptive as currently.

  • Much of the current compliance, disclosure and reporting requirements would be removed for non-aligned advisers, enabling them to reduce the cost of advice and service a much wider market.

  • 'Assets under management' fees would be abolished for both aligned and non-aligned advisers. Fees would be charged on an hourly basis or on an agreed retainer basis. These fees should be tax deductible.

  • Both aligned and non-aligned advisers would be required to disclose the annual costs in dollar and percentage terms of all charges paid by clients for financial services provided, arranged and managed by the adviser, including advice, administration, fund manager, loan and personal risk insurance costs. Also, standard illustrations of those charges should be provided to potential new clients so valid cost comparisons can be made at the time of choosing an adviser. This requirement would serve to nullify any under-pricing or subsidising of advice by product manufacturers to position themselves to win product-related business.

Non-aligned advisers would meet ASIC’s current definition of independence. Under the existing regime there is little to be gained from complying with this definition. There is no regulatory relief and the potential marketing advantage is drowned out by the noise of the large product manufacturers and their aligned advisers. Our experience is that without education most consumers, to their detriment, are not aware of the difference between an independent and non-independent adviser.

If the distinction is enhanced, along the lines proposed above, it is likely that more Australians will see non-aligned advisers as value for money sources of quality objective financial advice and acting only in clients’ best interests when recommending third party product solutions. Also, it may help to drive change within the advice industry, with more aligned advisers being attracted to the non-aligned space.

Given the proposed level of legislative support, it is possible to see how the fledgling non-aligned advisers could over time potentially evolve into a true profession, developing a relationship with industry not unlike that of doctors. The role of advisers could be restricted to advice with referrals to trusted brokers for product placement, enabling an adviser to look after many more clients at significantly lower cost than currently is the case.

In summary

My views are driven by a belief that financial product manufacturers should have a very limited role (if any) to play in the provision of financial advice to consumers. Their overriding reason for providing financial advice is to facilitate the sale of product, rather than seeing advice as the core business.

The resulting conflict of interest, together with confused consumers, will almost inevitably lead to future misselling disasters. Legislating 'best interest' and a focus on financial literacy are band-aid solutions that do not reach the heart of the problem.

As in the provision of medical services, financial advice needs to be separated from product to increase the chances that providers of advice are intrinsically driven by their clients’ welfare.

 

John Leske is a Principal of Wealth Foundations. This article is general advice only as it does not take into account the objectives, financial situation or needs of any particular person.

5 Comments
Mike
April 30, 2018

Puzzling how Leigh, like many observers, seems to say that financial advisers should be held to a lower standard than, say, nurses and medical doctors who have a duty of care.
Such roles are normally sanctioned- quite heavily- if they do not demonstrate the skills or inclination to deliver a safe result to a person considered their 'client'.

The work product of financial advisers is equally able to ruin the savings, homes, health and well-being of their clients, yet many baulk at the same care standard being applied by society.

Despite having consulted extensively in the industry I really fail to see why such a standard is 'fraught with problems' as Leigh suggests? It has proved quite workable across a range of roles in industries including health, transport and others. All it needs is commitment, training and resources.

If this means fee-for-service becomes equivalent to [say] hourly rates for a CPA, then at least clients could assess this in light of task complexity and the relative confidence they could take from the result.

AMP Adviser
April 30, 2018

[Editing note: the original question in this comment directed at other AMP advisers is better placed on a financial adviser website].

Jeff Wain
April 30, 2018

Well said John. This has been a long time coming. Hopefully some time soon we will be able to answer in the affirmative to the seemingly eternal question. "Are we there yet?"

George
April 26, 2018

Most of your points make sense, however, the last point regarding cost. This is already provided to client in the form of a Statement of Advice before anything is implemented, which outlines all the costs in both dollar and percentage. On an ongoing basis there is the Fee disclosure statement which shows the income the adviser has received for a 12 month period.

How much more fee disclosure do you need? Clients will also receive PDS, statements from investment managers that also disclose product fees and in some cases adviser fees where applicable.

In my opinion, Statements of Advice need to be reviewed and simplified, they can be confusing, but this is due to regulated requirements that need to be included. I am all for making advice better, however, we are missing the big picture, in order to make advice more affordable/accessible, it can't be done with additional requirements, and adding more work for the adviser, which increases costs. Just my 2 cents.

Leigh
April 26, 2018

I always thought requiring advisers to act in "the clients best interest" was fraught with problems and that the suggestion was made by someone from outside the industry.

It was simply never possible to put that responsibility on each individual adviser when their skills, knowledge and experience were so varied.

As for changes in the industry I think there should be significant changes in the industry structure and operations. Further, I feel it better to have the disruption through the system sooner in a matter of years rather than stretched over decades. It remains to be seen if the Royal Commission and the Government agrees.

 

Leave a Comment:

     
banner

Most viewed in recent weeks

Welcome to Firstlinks Edition 433 with weekend update

There’s this story about a group of US Air Force generals in World War II who try to figure out ways to protect fighter bombers (and their crew) by examining the location of bullet holes on returning planes. Mapping the location of these holes, the generals quickly come to the conclusion that the areas with the most holes should be prioritised for additional armour.

  • 11 November 2021

Why has Australia slipped down the global super ranks?

Australia appears to be slipping from the pantheon of global superstar pension systems, with a recent report placing us sixth. A review of an earlier report, which had Australia in bronze position, points to some reasons why, and what might need to happen to regain our former glory.

Welcome to Firstlinks Edition 431 with weekend update

House prices have risen at the fastest pace for 33 years, but what actually happened in 1988, and why is 2021 different? Here's a clue: the stockmarket crashed 50% between September and November 1987. Looking ahead, where did house prices head in the following years, 1989 to 1991?

  • 28 October 2021

How to help people with retirement spending decisions

Super funds will soon be required to offer retirement income strategies for members in decumulation. With uncertain returns, uncertain timelines, and different goals, it's possibly “the hardest, nastiest problem in finance".

Tips when taking large withdrawals from super

You want to take a lump sum from your super, but what's the best way? Should it come from you or your spouse, or the pension or accumulation account. There is a welcome flexibility to select the best outcome.

“Trust your instinct” Hamish Douglass in conversation with Sir Frank Lowy AC

Sir Frank shares his story, including his journey from war-torn Europe, identifying opportunities, key character traits necessary for business success, and the importance of remaining paranoid yet optimistic.

Latest Updates

Investment strategies

20 punches: my personal investments are not a forecast

I prefer not to make market forecasts but I need to take personal investment decisions. I'm expecting a stockmarket fall in 2022 as central banks tighten policies but the mainstays in my portfolio will not be sold.

Retirement

The good news about retirement income

A lower starting withdrawal rate doesn’t always mean living on less. The latest research on sustainable withdrawals offers flexibility for retirees to improve the chances of not running out of funds prematurely.

Shares

Three small companies expected to deliver big returns

Small caps might require more work than large cap stocks but they are often worth it. After all, all large companies were small once, and there can be clear benefits of investing in and backing management early.

5 new trends driving the future of biotech companies

The biotech industry has seen an explosion of new techniques which will lead to innovative areas of growth in the use of cells and genes as medicine. Money for funding life sciences and biotech pharma has soared.

Gold

Gold and inflation: what does history tell us?

Multiple factors have seen gold fall in 2021, despite the rise in inflation. But given gold has performed strongly across longer periods of higher inflation, gold may benefit under the current inflation outlook.

  • 8 December 2021
Retirement

Solutions to unite the three pillars of retirement funding

Retirement solutions uniting the three pillars of retirement funding - the age pension, mandatory super and voluntary savings - are essential. Global experts discuss solutions that might work for Australia.

Investment strategies

New capital rules an effective vaccine for thriving banks

With stronger capital positions, improved brand equity and the potential to benefit from a robust post-pandemic recovery, the global banking sector is presenting significant opportunities for investors.

Sponsors

Alliances

© 2021 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.